Origin issues update on R&D pipeline
Chinese agricultural biotechnology company Origin Agritech (Beijing) is to expand the number of maize hybrids incorporating a genetic modification that results in the production of the enzyme, phytase, in grain. It already has two hybrid lines awaiting final approval from Chinese regulators and is now seeking to add the trait to a further two hybrid lines. The availability of grain for feed that incorporates phytase will reduce feed manufacturers’ costs by eliminating the need for the use of an additive, the company says. The phytase-producing maize will also reduce the need for adding inorganic phosphate supplements to feed as animals will directly absorb more phosphate from their feed, reducing costs, it adds.